Core Laboratories to Post Q1 Earnings: Key Metrics to Watch

Zacks Zacks 在Zacks上打开
Core Laboratories to Post Q1 Earnings: Key Metrics to Watch

Core Laboratories Inc. CLB is set to release first-quarter 2026 results on April 29, after the closing bell. The Zacks Consensus Estimate for the to-be-reported quarter is pegged at a profit of 6 cents per share on revenues of $122.95 million.

Let us delve into the factors that might have influenced CLB’s performance in the to-be-reported quarter. Before that, it is worth taking a look at the company’s performance in the last reported quarter.

Highlights of Q4 Earnings & Surprise History

In the last reported quarter, the Houston, TX-based oil and gas equipment and services company’s adjusted earnings beat the consensus mark. CLB reported adjusted earnings of 21 cents per share, which was a cent higher than the Zacks Consensus Estimate. Operating revenues of $138.3 million beat the Zacks Consensus Estimate of $132 million. This was attributed to the amplified demand for CLB’s laboratory analytical services and complete diagnostic services in international regions.

CLB’s earnings beat the Zacks Consensus Estimate in three of the trailing four quarters and missed the remaining one, delivering an average surprise of 4.9%.

This is depicted in the graph below:

Core Laboratories Inc. Price and EPS Surprise

Core Laboratories Inc. Price and EPS Surprise

Core Laboratories Inc. price-eps-surprise | Core Laboratories Inc. Quote

CLB Stock’s Trend in Estimate Revision

The Zacks Consensus Estimate for first-quarter 2026 earnings has remained unchanged in the past seven days. The estimated figure indicates a 57.1% year-over-year decline. The Zacks Consensus Estimate for revenues also indicates a decline of about 0.5% from the year-ago period’s actual.

Factors to Consider Ahead of CLB’s Q1 Release

Core Laboratories is facing a confluence of near-term headwinds that materially increase the likelihood of an earnings miss in the first quarter of 2026. The company has already revised its guidance downward due to escalating geopolitical instability in the Middle East, which has disrupted client activity through project delays, travel restrictions and supply-chain bottlenecks. Damage to regional oil infrastructure and logistical constraints, particularly around the Strait of Hormuz, have curtailed production and hindered project execution, with Reservoir Description disproportionately impacted due to its reliance on field access and sample movement. Additionally, adverse weather events in North America and Europe further disrupted operations, compounding seasonal weakness typically seen in the first quarter. Tariff-driven cost inflation, rising labor expenses and higher interest costs from new variable-rate debt add margin pressure. The company brought down its total revenue expectations to a range of $119-$123 million from the earlier expected $124-$130 million. Operating income (ex-items) is now expected to range between $5.7 million and $7.1 million. Also, earnings per share (ex-items) are now expected to range between 5 and 7 cents, brought down from the earlier expected 11-15 cents.

Despite near-term disruptions, Core Laboratories retains several levers that could support an earnings beat. Production Enhancement remains relatively resilient, with strong demand for diagnostic services and technological solutions helping offset weakness in other segments. The company’s asset-light model and disciplined cost management could preserve margins better than expected, while mitigation efforts around tariffs and supply chains may ease cost pressures.

What Does Our Model Say About CLB Stock?

Our proven model does not conclusively predict an earnings beat for Core Laboratories this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. This is not the case here.

CLB’s Earnings ESP: Earnings ESP, which represents the difference between the Most Accurate Estimate and the Zacks Consensus Estimate, for this company is 0.00%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

CLB’s Zacks Rank: CLB currently carries a Zacks Rank #4 (Sell).

Stocks With the Favorable Combination

Here are some firms from the energy space that you may want to consider, as these have the right combination of elements to post an earnings beat this reporting cycle.

ConocoPhillips COP has an Earnings ESP of +8.05% and a Zacks Rank #1 at present. You can see the complete list of today’s Zacks #1 Rank stocks here.

COP is scheduled to release earnings on April 30. Notably, theZacks Consensus Estimate for COP’s 2026 earnings indicates 18.5% year-over-year growth. Valued at around $146.6 billion, COP’s shares have gained 36.6% in a year.

Forum Energy Technologies, Inc. FET has an Earnings ESP of +4.55% and a Zacks Rank #3 at present. FET is slated to release earnings on April 30.

The Zacks Consensus Estimate for FET’s 2026 earnings indicates 220.6% year-over-year growth.Valued at around $651.2 million, FET’s shares have soared 295% in a year.

Valero Energy Corporation VLO has an Earnings ESP of +1.83% and a Zacks Rank #1 at present. It is scheduled to release earnings on April 30.

The Zacks Consensus Estimate for VLO’s 2026 earnings indicates 79.4% year-over-year growth.Valued at around $69.8 billion, VLO’s shares have surged 108.1% in a year.

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
ConocoPhillips (COP): Free Stock Analysis Report
 
Core Laboratories Inc. (CLB): Free Stock Analysis Report
 
Valero Energy Corporation (VLO): Free Stock Analysis Report
 
Forum Energy Technologies, Inc. (FET): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research